dihexa neurotrophic effects (PNB-0408) | c-Met/HGFR Activator Peptide Therapy: A Promising mg:20mg X 5pk TAA Compliant

dihexa neurotrophic effects (PNB-0408) | c-Met/HGFR Activator Peptide Therapy: A Promising mg:20mg X 5pk TAA Compliant

Peptide Therapy: A Promising New Emerging Science

(2021) demonstrated that Lycopodium selago L

TAA Compliant

mg:20mg X 5pk

Injection burden 2-3 injections per day on TB-500 days Best for Dose flexibility, injury-focused work Cycle driver GHK-Cu cycling typically sets the cycle length BPC-157 Loading 250-500 mcg/day (weeks 1-4) Frequency Daily Maintenance 250 mcg/day (weeks 5-8+) Route SubQ near injury or oral TB-500 Loading 2.5-5 mg per injection (weeks 1-4) Frequency 2x/week Maintenance 2 mg per injection (weeks 5-8+) Route SubQ systemic GHK-Cu Loading 1-2 mg/day (weeks 1-4) Frequency Daily Maintenance 1 mg/day (weeks 5-8+) Route SubQ Weekly Schedule Example Monday BPC-157 500 mcg + TB-500 2.5 mg + GHK-Cu 1-2 mg Tuesday BPC-157 500 mcg + GHK-Cu 1-2 mg Wednesday BPC-157 500 mcg + GHK-Cu 1-2 mg Thursday BPC-157 500 mcg + TB-500 2.5 mg + GHK-Cu 1-2 mg Friday BPC-157 500 mcg + GHK-Cu 1-2 mg Saturday BPC-157 500 mcg + GHK-Cu 1-2 mg Sunday BPC-157 500 mcg + GHK-Cu 1-2 mg Use a separate syringe for each compound